Research Misconduct - FFP (Falsification, Fabrication and Plagiarism)

1. Definition of Research Misconduct

Research misconduct is defined by international and national scientific regulatory bodies as the intentional violation of standard codes of scholarly conduct and ethical behavior in professional scientific research. The core triad of research misconduct is universally recognized as "FFP": Fabrication, Falsification, and Plagiarism. Importantly, research misconduct requires deliberate intent or gross negligence; it explicitly does not include honest errors or legitimate differences in interpretation of clinical data.

2. The "FFP" Triad

A. Fabrication

• Definition: The act of making up data, clinical findings, or experimental results, and recording or reporting them as factual.
• Examples in Pediatrics: Creating fictitious patient case report forms (CRFs) to inflate the sample size of a clinical trial, inventing laboratory values for a study cohort, or forging informed consent signatures from non-existent trial participants.

B. Falsification

• Definition: The manipulation of research materials, equipment, or processes, or the deliberate alteration or omission of data or results such that the research is not accurately represented in the scientific record.
• Examples in Pediatrics: Selectively deleting "outlier" data points in an anthropometric study to force statistical significance ($p<0.05$), tampering with diagnostic equipment to alter readings, or digitally manipulating radiological images or Western blots to exaggerate a clinical finding.

C. Plagiarism

• Definition: The appropriation of another person’s ideas, processes, results, or words without giving appropriate credit and attribution.
• Subtypes of Plagiarism:
  • Direct (Verbatim) Plagiarism: Copying text word-for-word from a source without using quotation marks and proper citation.
  • Mosaic (Patchwork) Plagiarism: Borrowing phrases from multiple sources and integrating them into one's own text without altering the core structure or meaning, even if synonyms are substituted.
  • Idea Plagiarism: Using a unique hypothesis, clinical algorithm, or conceptual framework developed by someone else without acknowledgment.
  • Self-Plagiarism (Text/Data Recycling): Republishing one's own previously published work (text, data, or figures) in a new manuscript without disclosing the original publication, leading to redundant or duplicate publication.

3. Regulatory Framework and Guidelines

• COPE (Committee on Publication Ethics): Provides standardized international flowcharts and protocols for medical journal editors to handle suspected FFP.
• ICMR (Indian Council of Medical Research): The National Ethical Guidelines mandate strict adherence to research integrity and lay down protocols for Institutional Ethics Committees (IEC) to investigate misconduct.
• UGC (University Grants Commission) Regulations (India): Mandates acceptable limits of text similarity (excluding quotes, bibliography, and generic terms) for postgraduate theses and publications:
  • Level 0: Similarities up to 10% (Minor, no penalty).
  • Level 1: 10% to 40% (Student asked to submit a revised manuscript/thesis within a stipulated time).
  • Level 2: 40% to 60% (Student debarred from submitting a revised manuscript for a period of 1 year).
  • Level 3: >60% (Student registration for the postgraduate program is cancelled).

4. Detection and Investigation

• Screening Tools: Mandatory pre-submission screening of manuscripts and thesis protocols using sophisticated text-matching software (e.g., Turnitin, iThenticate, Urkund).
• Data Audits: Institutional mechanisms and regulatory bodies (e.g., CDSCO in India) conducting unannounced audits of raw data during clinical trials.
• Whistleblower Policies: Establishing confidential reporting mechanisms to protect junior researchers who report senior staff or principal investigators for suspected FFP.

5. Consequences and Penalties

• Academic/Institutional: Termination of employment, cancellation of postgraduate registration (DNB/MD), or revocation of already awarded medical degrees.
• Scientific: Formal retraction of the published article with a public "Notice of Retraction" detailing the misconduct; blacklisting of the authors by academic journals.
• Financial/Legal: Debarment from receiving future research funding from national agencies (e.g., DST, ICMR), and potential civil or criminal liability if patient harm occurred due to fabricated clinical trial protocols.

6. Prevention Strategies

• Mandatory integration of Good Clinical Practice (GCP), research methodology, and biomedical ethics modules into the postgraduate medical curriculum.
• "Open Science" initiatives requiring the deposition of raw, anonymized clinical datasets into public repositories prior to journal publication to allow independent verification.
• Active, transparent, and accountable mentorship by senior faculty during the thesis writing process.